gemcitabine has been researched along with halichondrin b in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhesy-Thind, B; Doyle, L; Goffin, JR; Hedley, D; Krzyzanowska, MK; Major, P; Moore, MJ; Renouf, DJ; Tang, PA; Wang, L | 1 |
1 trial(s) available for gemcitabine and halichondrin b
| Article | Year |
|---|---|
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Agents; Deoxycytidine; Drug Resistance, Neoplasm; Ethers, Cyclic; Female; Furans; Gemcitabine; Humans; Ketones; Macrolides; Male; Middle Aged; Pancreatic Neoplasms; Tubulin Modulators | 2012 |